Skip to main content

theophylline

NDC 60219-2046 · Amneal Pharmaceuticals NY LLC

Generic nametheophylline
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
Active ingredient(s)THEOPHYLLINE ANHYDROUS
Strength450 mg/1
Pharmacologic classMethylxanthine [EPC], Xanthines [CS]
Marketing categoryANDA

Packages

60219-2046-1 — 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (60219-2046-1)

60219-2046-3 — 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (60219-2046-3)

60219-2046-5 — 500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (60219-2046-5)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

42291-922 — Theophylline, 46708-025 — Theophylline, 46708-026 — Theophylline, 51407-318 — Theophylline, 51407-319 — Theophylline, 52244-100 — theophylline anhydrous, 52244-200 — theophylline anhydrous, 52244-300 — theophylline anhydrous, 52244-400 — theophylline anhydrous, 60219-2045 — theophylline, 62135-457 — Theophylline, 62135-556 — Theophylline, 62332-025 — Theophylline, 62332-026 — Theophylline, 64380-243 — Theophylline, 64380-244 — Theophylline, 68462-356 — Theophylline, 68462-380 — Theophylline, 68462-721 — Theophylline, 68462-722 — Theophylline, +22 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.